IRCT201211211556N48已完成2 期
Riluzole as adjuvant therapy in the treatment of OCD: a double blind randomized trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: 1-Age between 18-60, 2-Diagnosis of OCD based on DSM IV 3 , Minimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale-
排除标准
- •1- Substance dependence,2- IQ less than 70,3-any other mental disorder on axis I, 4-Any serious cardiac, renal or hepatic disease ,5- receiving psychotropic medications during the last 6 weeks 6- pregnancy or breast feeding 7-rising liver transaminases to three times the upper limit of normal or highe
研究者
相似试验
已完成
2 期
Riluzole in the treatment of major depressioMajor Depressive episode.Major Depressive episodeIRCT201307181556N54Tehran University of Medical Sciences40
已完成
不适用
Riluzol effect on treatment of drug resistant obsessive obsessive compulsive disorderObsessive-compulsive disorder.Obsessive-compulsive disorderIRCT20151103024853N5Deputy of research and technology developement32
已完成
2 期
Riluzole in the treatment of autismChildhood autism.Childhood autismIRCT201107281556N27Tehran University of Medical Sciences40
已完成
2 期
ondansetron in the treatment of obsessive-compulsive disorderObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT201204271556N41Tehran University of Medical Sciences40
进行中（未招募）
1 期
Palbociclib plus letrozole for menopausal women with localized breast cancerHormone receptor (HR) positive / HER2-negative localized breast cancer in menopausal patient considered as having an intermediate risk of relapse.EUCTR2019-004899-19-FRICANCER1,500